Presented at #HeartFailure2024: Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamten led to a greater increase in peak oxygen consumption than placebo at 6 months. Full SEQUOIA-HCM phase 3 trial results: nej.md/3wmDzyl

The KCMO score: intuitive (% of ideal 💊), patient-centric, can adapt as guidelines ∆, ↑ granularity vs existing methods. The new way to ⚖️ GDMT." Mirza Khan Saint Luke's Mid America Heart Institute @GCFMD Nobuhiro Ikemura @javedbutler1 Charles F. Sherrod IV, M.D., M.Sc. #AHAJournals ahajrnls.org/3VC3yLQ

Congrats Mirza Khan more work to be done!

Let’s be clear: Donald Trump would sign a national abortion ban and restrict access to contraception if given the chance. That is what’s at stake in November. We will stop him.

🔥 📄 SEQUOIA-HCM 🔥 European Society of Cardiology #ESCCongress JACC Journals symptomatic oHCM aficamten vs placebo Improved KCCQ, 👇chest pain Led by T32 fellow, rising 🌟 Charles Sherrod Saint Luke's Mid America Heart Institute KCCQ guru and mentor John Spertus Editorial response by Nosheen Reza, MD, MS

We’ve got “Pink Pony Club” on repeat after @chappellroan’s win at the #VMAs. Congrats to the Best New Artist, and thanks for this iconic lifesaving beat. If you see a teen or adult collapse, call 911 and push hard and fast in the center of the chest. @mtv #NationofLifesavers

Congrats Michael Nassif and Saint Luke's Mid America Heart Institute !

Congrats Dan Nguyen! Saint Luke's Mid America Heart Institute

US Maternal Mortality is alarmingly high and cardiovascular conditions are lead cause. ❤️‍🩹🩺🤰🏻 Our Healthcare Institute for Innovations in Quality investigators @DoFlorio John Spertus & Anna Grodzinsky have received the largest NIH grant in UMKC history to improve this. ‼️ Let’s go team! 🔥 umkc.edu/news/posts/202…

An informative editorial by Michelle Kittleson MD PhD summarizing the background, context and findings from 4 studies in JACC Journals from the #SEQUOIA #HCM trial Great to see a whole issue of JACC Journals dedicated to #HCM jacc.org/doi/epdf/10.10… #CardioTwitter

In this study, the Kansas City Cardiomyopathy Questionnaire (KCCQ) was a reliable and responsive measure of patient-reported health status in individuals with severe tricuspid regurgitation undergoing transcatheter tricuspid valve interventions. ja.ma/3NInl7x #TCT2024

Congrats to Mohd Jawad on this amazing study! Saint Luke's Mid America Heart Institute

Small mean treatment effects in heart failure trials may still lead to clinically meaningful improvements for a significant proportion of patients. #AHA24 ja.ma/3UOU52T

We are excited to announce that the U.S. FDA approved our orally-administered near-complete (≥90%) stabilizer of TTR for the treatment of adult patients with transthyretin cardiac amyloidosis (ATTR-CM). We are proud of the opportunity to serve patients within this community.

.Stephen Cook, et al., conducted a voluntary survey of #ACCFITs & #ACCEarlyCareer cardiologists to evaluate #LGBTQ+ representation, potential sources of mistreatment & measures of wellness among the cardiovascular workforce. 🔗 bit.ly/4gkTjms #ACCPride #JACCAdvances

📢 The Kansas City Cardiomyopathy Questionnaire (KCCQ-23) vs. NYHA Class in Obstructive Hypertrophic Cardiomyopathy 🔹 our brief report in Journal of Cardiac Failure explores how KCCQ-23 scores align with NYHA class in patients with obstructive hypertrophic cardiomyopathy (oHCM). 💡 Key

Congratulations TIARA Scholars implementing evidence into practice! 👏🏻 Today was the Certificate Ceremony & Keynote on the “Future of Implementation Practice” with Anne Sales Healthcare Institute for Innovations in Quality Frontiers CTSI 🩺📖💕 👑 healthcareinstitute.umkc.edu/professional-t…

Understanding patient-reported outcomes in obstructive hypertrophic cardiomyopathy (oHCM) is vital for managing treatment effectively. We recently validated the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) in this population. Here’s why it matters: A quick🧵

Congrats, Omar! Great news for patients and great mentorship from Andrew J Sauer MD

Congrats Omar!!